Hippo pathway signaling associated with immune cell trafficking in colorectal cancer.

Authors

null

Natsuko Kawanishi

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA

Natsuko Kawanishi , Joanne Xiu , Hiroyuki Arai , Francesca Battaglin , Priya Jayachandran , Shivani Soni , Jae Ho Lo , Wu Zhang , Pavel Brodskiy , Anthony Frank Shields , John Marshall , Emil Lou , Jim Abraham , W. Michael Korn , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Translational Research

DOI

10.1200/JCO.2022.40.4_suppl.156

Abstract #

156

Poster Bd #

K10

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Annual Meeting

Comprehensive characterization of <em>PTPRT</em> expression in colorectal cancer (CRC).

Comprehensive characterization of PTPRT expression in colorectal cancer (CRC).

First Author: Francesca Battaglin

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.

Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.

First Author: Karam Ashouri

Poster

2021 ASCO Annual Meeting

HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.

HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.

First Author: Tenley Klc

Poster

2021 ASCO Annual Meeting

Exploring molecular profiles and survival in hormone receptor-positive uterine serous carcinoma.

Exploring molecular profiles and survival in hormone receptor-positive uterine serous carcinoma.

First Author: Amaranta Craig